Last reviewed · How we verify

NCT04165902

Additional Effects of Steroid and Dextrose to Hyaluronic Acid on Knee Osteoarthritis

Status unknown Phase 4 Last updated 19 November 2019
What this trial tests

Phase 4 trial testing compare the effects of steroid plus hyaluronic acid and destrose plus hyaluronic acid on knee osteroarthritis in Knee Osteoarthritis in 60 participants. Status unknown.

Timeline
11 November 2019
Primary endpoint
31 July 2020
31 July 2020

Quick facts

Lead sponsorTaipei Medical University
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment60
Start date11 November 2019
Primary completion31 July 2020
Estimated completion31 July 2020
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Taipei Medical University

Who can join

Adults 40 to 85, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using double-blind, randomized controlled design to compare the immediate, short-term and intermediate-term additional therapeutic effects of ultrasound-guided corticosteroid injection and dextrose injection of hyaluronic acid injection on patients with knee osteoarthritis, under the basis of International Classification of Functioning, Disability, and Health.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Designing functional hyaluronic acid-based hydrogels for cartilage tissue engineering.
    Wang M, Deng Z, Guo Y, Xu P. · · 2022 · cited 52× · PMID 36420054 · DOI 10.1016/j.mtbio.2022.100495

Verify or expand the search:

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other Taipei Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04165902.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing